Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |